Researchers hope to improve survival rates through early detection with a blood test that can detect over 50 types of cancer.
Grail's Galleri test screens for more than 50 different types of cancer from a single blood draw. (Getty Images) If you could take a simple blood test that could detect multiple types of cancer while ...
Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...
ST. LOUIS, Jan. 8, 2026 /PRNewswire/ -- Mercy is participating in a study designed to evaluate the clinical impact of GRAIL's Galleri (R) multi-cancer early detection (MCED) test among Medicare ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...
Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...
This indicates that the test is as effective as colonoscopy in reducing colorectal cancer mortality in screening [programs],” ...
Blood-based Shield Multi-Cancer Detection (MCD) test exhibits high specificity, clinically meaningful sensitivity and strong cancer signal of origin accuracy Results informed National Cancer Institute ...
What if a single blood test could determine whether you had one of 14 types of cancer? That's the question posed by a study published in November in the journal Cancer. Conducted by researchers at the ...
Health disruptors are introducing new ways to screen for cervical cancer that skip the speculum entirely. And Teal's the first to bring at-home screening to women in all 50 states.
If you could take a simple blood test that could detect multiple types of cancer while they’re still in an early and treatable stage, would you? For many, the answer would be a resounding yes.